Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted) Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 36.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.89% |
| Dec 31, 2025 | 32.90% |
| Sep 30, 2025 | 11.51% |
| Jun 30, 2025 | 17.79% |
| Mar 31, 2025 | 13.36% |
| Dec 31, 2024 | 10.81% |
| Sep 30, 2024 | -3.69% |
| Jun 30, 2024 | 3.48% |
| Mar 31, 2024 | -10.48% |
| Dec 31, 2023 | -56.78% |
| Sep 30, 2023 | 3.06% |
| Jun 30, 2023 | -37.85% |
| Mar 31, 2023 | -81.37% |
| Dec 31, 2022 | -60.55% |
| Sep 30, 2022 | -69.69% |
| Jun 30, 2022 | -87.92% |
| Mar 31, 2022 | -116.52% |
| Dec 31, 2021 | -47.12% |
| Sep 30, 2021 | -43.23% |
| Jun 30, 2021 | -47.77% |
| Mar 31, 2021 | -55.87% |
| Dec 31, 2020 | -39.16% |
| Sep 30, 2020 | -40.69% |
| Jun 30, 2020 | -17.29% |
| Mar 31, 2020 | -2.33% |
| Dec 31, 2019 | 65.10% |
| Sep 30, 2019 | 90.28% |
| Jun 30, 2019 | 95.74% |
| Mar 31, 2019 | 61.63% |
| Dec 31, 2018 | -3.01% |
| Sep 30, 2018 | 64.89% |
| Jun 30, 2018 | 95.41% |
| Mar 31, 2018 | -25.75% |
| Dec 31, 2017 | -35.32% |
| Sep 30, 2017 | 107.15% |
| Jun 30, 2017 | -29.44% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 4.66% |
| Sep 30, 2016 | 28.86% |
| Jun 30, 2016 | 36.10% |
| Mar 31, 2016 | 65.95% |
| Dec 31, 2015 | -1.87% |
| Sep 30, 2015 | 27.25% |
| Jun 30, 2015 | 26.62% |
| Mar 31, 2015 | -11.78% |